Publications by authors named "Chang-Ching Lin"

Claim this Profile
C
CD8+ T cells in the tumor microenvironment modulate response to endocrine therapy in breast cancer.
Fabiana Napolitano, Yunguan Wang, Dhivya R Sudhan, Paula I Gonzalez-Ericsson, Luigi Formisano, Chang-Ching A Lin, Lin Xu

J Clin Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer" [604 (2024) 217219 1-12].
María Rosario Chica-Parrado, Gun Min Kim, Yasuaki Uemoto, Fabiana Napolitano, Chang-Ching Lin

Cancer Lett· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.
Maxwell R Lloyd, Rosario Chica-Parrado, Caroline M Weipert, Todd C Knepper, Emily L Podany, Chang-Ching Lin

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations.
Yasuaki Uemoto, Chang-Ching A Lin, Bingnan Wang, Dan Ye, Yisheng V Fang

Cancer Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental mixed-gender preferences revealed by IVF twin births.
C Y Cyrus Chu, Chang-Ching Lin, Shih-Ting Lu, Ching-Yuan Kao

Proc Natl Acad Sci U S A· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.
Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni, Ellen Jaeger, Yisheng V Fang, Lin Xu

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why does AI hinder democratization?
C Y Cyrus Chu, Juin-Jen Chang, Chang-Ching Lin

Proc Natl Acad Sci U S A· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CDK4-selective inhibitor puts the brakes on cancer cells.
Chang-Ching Lin, Ariella B Hanker

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.
María Rosario Chica-Parrado, Gun Min Kim, Yasuaki Uemoto, Fabiana Napolitano, Chang-Ching Lin

Cancer Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of a Compact Multiband Monopole Antenna with MIMO Mutual Coupling Reduction.
Chang-Keng Lin, Ding-Bing Lin, Han-Chang Lin, Chang-Ching Lin

Sensors (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Lin Xu

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Lin Xu

Res Sq· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer.
Kyung-Min Lee, Chang-Ching Lin, Alberto Servetto, Joonbeom Bae, Vishal Kandagatla

Cancer Immunol Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER Breast Cancer.
Alberto Servetto, Rahul Kollipara, Luigi Formisano, Chang-Ching Lin, Kyung-Min Lee

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.
Ariella B Hanker, Benjamin P Brown, Jens Meiler, Arnaldo Marín, Harikrishna S Jayanthan, Chang-Ching Lin

Cancer Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Loss of Lifetime Employment Duration for Patients Undergoing Maintenance Dialysis in Taiwan.
Yu-Tzu Chang, Fuhmei Wang, Wen-Yen Huang, Hsuan Hsiao, Jung-Der Wang, Chang-Ching Lin

Clin J Am Soc Nephrol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer.
Kyung-Min Lee, Angel L Guerrero-Zotano, Alberto Servetto, Dhivya R Sudhan, Chang-Ching Lin, Melinda E Sanders

Nat Commun· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.
Mari Gasparyan, Miao-Chia Lo, Hui Jiang, Chang-Ching Lin, Duxin Sun

J Biol Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173].
Chang-Ching Lin, Miao-Chia Lo, Rebecca Moody, Hui Jiang, Ramdane Harouaka

Cancer Lett· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of Out-Of-Hospital Access to HIS System: A Security Perspective.
Chih-Yung Chen, Yi-Chang Hsu, Chang-Ching Lin, Jeyhun Hajiyev, Chia-Rong Su

Sensors (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
Chang-Ching Lin, Miao-Chia Lo, Rebecca Moody, Hui Jiang, Ramdane Harouaka

Cancer Lett· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells.
Chang-Ching Lin, Miao-Chia Lo, Rebecca R Moody, Nicholas O Stevers, Samantha L Tinsley

Oncol Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Numb chin syndrome associated with vertical root fracture and odontogenic infection.
John K Brooks, Kevin G Schwartz, Alvin S Ro, Chang-Ching D Lin

Quintessence Int· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes.
Rebecca Reed Moody, Miao-Chia Lo, Jennifer L Meagher, Chang-Ching Lin, Nicholas O Stevers

J Biol Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.
Lichao Sun, Joseph Burnett, Mari Gasparyan, Fangying Xu, Hui Jiang, Chang-Ching Lin

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis